Target Market Veterinary clinics and hospitals with a focus on senior dog care and preventive health screenings present a ready channel for Nu.Q Vet Cancer Test adoption, especially those offering annual wellness checks and routine cancer risk assessments.

Affordability Advantage Position the test as a cost-effective, easy-to-use screening option that reduces downstream diagnostic burden for owners and clinics, which can drive higher trial uptake in practices seeking value-driven solutions.

Strategic Partnerships Leverage collaboration history with Texas A&M and ongoing research momentum to approach veterinary schools, oncology departments, and credentialed specialty clinics for pilot programs and case studies.

Global Expansion Capitalize on the availability in over 20 countries by targeting international veterinary networks, distributors, and e-commerce channels to accelerate adoption in markets with rising pet healthcare investment.

Awareness & Education Develop thought leadership and training materials around early cancer detection in dogs to support veterinarians’ confidence in using screening tests, increasing referrals and repeat usage during wellness visits.